Securian Asset Management, Inc Halozyme Therapeutics, Inc. Transaction History

Securian Asset Management, Inc

$3.44 Billion
Q2 2025

A detailed history of Securian Asset Management, Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Securian Asset Management, Inc holds 9,384 shares of HALO stock, worth $611,836. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,384

Previous 9,618 2.43%

Holding current value

$611,836

Previous $613,000 20.39%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	SELL	$47.91 - $70.14 $11,210 - $16,412	-234 Reduced 2.43%	9,384 $488,000
Q4 2024 Feb 10, 2025	SELL	$42.57 - $61.09 $9,876 - $14,172	-232 Reduced 2.36%	9,618 $459,000
Q3 2024 Nov 13, 2024	SELL	$51.3 - $64.42 $15,441 - $19,390	-301 Reduced 2.97%	9,850 $563,000
Q2 2024 Jul 15, 2024	SELL	$37.81 - $52.4 $26,656 - $36,942	-705 Reduced 6.49%	10,151 $531,000
Q1 2024 Apr 26, 2024	SELL	$33.68 - $41.95 $7,308 - $9,103	-217 Reduced 1.96%	10,856 $441,000
Q4 2023 Feb 08, 2024	SELL	$33.32 - $42.1 $3,332 - $4,210	-100 Reduced 0.9%	11,073 $409,000
Q3 2023 Oct 30, 2023	SELL	$36.46 - $44.03 $20,308 - $24,524	-557 Reduced 4.75%	11,173 $426,000
Q2 2023 Aug 07, 2023	SELL	$30.28 - $38.74 $17,683 - $22,624	-584 Reduced 4.74%	11,730 $423,000
Q1 2023 Apr 27, 2023	SELL	$32.86 - $55.7 $3,647 - $6,182	-111 Reduced 0.89%	12,314 $470,000
Q4 2022 Feb 02, 2023	SELL	$40.06 - $59.44 $4,286 - $6,360	-107 Reduced 0.85%	12,425 $706,000
Q2 2022 Aug 04, 2022	SELL	$37.35 - $48.3 $3,735 - $4,830	-100 Reduced 0.79%	12,532 $551,000
Q1 2022 May 03, 2022	BUY	$31.97 - $41.06 $735 - $944	23 Added 0.18%	12,632 $504,000
Q4 2021 Feb 10, 2022	SELL	$31.82 - $40.75 $4,932 - $6,316	-155 Reduced 1.21%	12,609 $507,000
Q3 2021 Nov 08, 2021	BUY	$38.47 - $46.42 $17,850 - $21,538	464 Added 3.77%	12,764 $519,000
Q2 2021 Aug 10, 2021	BUY	$38.84 - $51.31 $13,788 - $18,215	355 Added 2.97%	12,300 $559,000
Q1 2021 May 10, 2021	SELL	$39.51 - $51.45 $3,951 - $5,145	-100 Reduced 0.83%	11,945 $498,000
Q4 2020 Feb 08, 2021	BUY	$25.81 - $43.62 $310,881 - $525,402	12,045 New	12,045 $514,000

Others Institutions Holding HALO

# of Institutions

606

Shares Held

127M

Call Options Held

408K

Put Options Held

388K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.08B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.

Account

Securian Asset Management, Inc Halozyme Therapeutics, Inc. Transaction History